The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNanoco Regulatory News (NANO)

Share Price Information for Nanoco (NANO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.58
Bid: 18.40
Ask: 18.60
Change: -0.27 (-1.43%)
Spread: 0.20 (1.087%)
Open: 18.48
High: 18.58
Low: 18.40
Prev. Close: 18.85
NANO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

High Court Confirmation of Capital Reduction

24 Jul 2023 07:00

RNS Number : 8773G
Nanoco Group PLC
24 July 2023
 

24 July 2023

NANOCO GROUP PLC

("Nanoco", the "Company" or the "Group")

 

High Court Confirmation of Capital Reduction

 

Nanoco Group plc (LSE: NANO), a world leader in the development and manufacture of cadmium-free quantum dots and other specific nanomaterials emanating from its technology platform, announces the confirmation by the High Court of the Capital Reduction.

On 7 July 2023, Resolutions for the Capital Reduction were approved by 99.8% of shareholders voting at the General Meeting held that day.

The Company is now pleased to announce that on 18 July 2023 the High Court of England and Wales sanctioned the cancellation of the amount standing to the credit of the Company's share premium reserve and the capital redemption reserve (the "Capital Reduction"). The Court order confirming the Capital Reduction, and a statement of capital approved by the Court in connection therewith, were sent to the Registrar of Companies who have now published on their website that the documents have been received and are being processed. The Capital Reduction will become fully effective upon the registration of these documents by the Registrar of Companies in the next ten days.

The purpose of the Capital Reduction is to create distributable reserves as described in the Circular and in accordance with the Company's Articles of Association.

The Capital Reduction will facilitate the previously announced return of capital to Shareholders of between £33 million and £40 million (or approximately 10 pence to 12 pence per share) using the second tranche of the proceeds of the Samsung litigation ($75 million) which is expected to be received during February 2024. No decision has yet been taken as to the method of any such return of capital.

As set out in the Circular, Nanoco also intends to retain approximately £20 million of cash (following the return to shareholders) to support near term commercial production opportunities, continuing R&D work on new materials, a proactive IP licensing programme, and to make Nanoco debt free and self-funded through to the self-financing position that is expected to be achieved during 2025.

- Ends -

A copy of the Circular is available on the Company's website at www.nanocotechnologies.com.

This summary should be read in conjunction with the full text of the Circular. Capitalised terms used but not defined in this announcement will have the same meaning given to them in the Circular.

FORWARD LOOKING STATEMENTS

This announcement (including information incorporated by reference in this announcement) and other information published by Nanoco may contain statements about Nanoco that are or may be deemed to be forward looking statements. Such statements are prospective in nature. All statements other than historical statements of facts may be forward looking statements. Without limitation, statements containing the words "targets", "plans", "believes", "expects", "aims", "intends", "will", "may", "anticipates", "estimates", "projects" or "considers" or other similar words may be forward looking statements.

Forward looking statements inherently contain risks and uncertainties as they relate to events or circumstances in the future. Important factors such as business or economic cycles, the terms and conditions of Nanoco's financing arrangements, tax rates, or increased competition may cause Nanoco's actual financial results, performance or achievements to differ materially from any forward looking statements. Due to such uncertainties and risks, readers are cautioned not to place undue reliance on such forward looking statements, which speak only as of the date hereof. Nanoco disclaims any obligation to update any forward looking or other statements contained herein, except as required by applicable law.

For further information, please contact:

Nanoco Group PLC: +44 (0) 1928 761 404

Brian Tenner, CEO

Liam Gray, CFO & Company Secretary

 

Peel Hunt (Joint Corporate Broker): +44 (0) 20 7418 8900

Paul Gillam

James Smith

 

Turner Pope Investments (Joint Corporate Broker):

Andrew Thacker +44 (0) 20 3657 0050

James Pope

 

MHP: +44 (0) 20 3128 8990

Reg Hoare

Matthew Taylor

Christian Harte

nanoco@mhpgroup.com

 

Notes for editors:

About Nanoco Group plc

Nanoco (LSE: NANO) harnesses the power of nano-materials. Nano-materials are materials with dimensions typically in the range 1 - 100 nm. Nano-materials have a range of useful properties, including optical and electronic. Quantum dots are a subclass of nano-material that have size-dependent optical and electronic properties. The Group produces quantum dots and other nano-materials. Within the sphere of quantum dots, the Group exploits different characteristics of the quantum dots to target different performance criteria that are attractive to specific markets or end-user applications such as the Display, Sensor and Electronics markets. An interesting property of quantum dots is their absorption spectrum. Nanoco's HEATWAVE™ quantum dots can be tuned to absorb light at different wavelengths across the near-infrared spectrum, rendering them useful for applications including image sensors. Another interesting property of quantum dots is photoluminescence: the emission of longer wavelength light upon excitation by light of a shorter wavelength. The colour of light emitted depends on the particle size. Nanoco's CFQD® quantum dots are free of cadmium and other toxic heavy metals, and can be tuned to emit light at different wavelengths across the visible and infrared spectrum, rendering them useful for a wide range of applications including displays, lighting and biological imaging.

Nanoco was founded in 2001 and is headquartered in Runcorn, UK, with a US subsidiary, Nanoco Inc., in Concord, MA. Nanoco continues to build out a world-class, patent-protected IP portfolio generated both by its own innovation engine, as well as through acquisition.

Nanoco is listed on the Main Market of the London Stock Exchange and trades under the ticker symbol NANO. For further information please visit: www.nanocotechnologies.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCRJMPTMTMTBLJ
Date   Source Headline
17th Sep 20187:00 amRNSHolding(s) in Company
11th Sep 20187:00 amRNSInvestor day
5th Sep 20182:21 pmRNSHolding(s) in Company
17th Aug 201811:28 amRNSHolding(s) in Company - Replacement
15th Aug 20184:47 pmRNSHolding(s) in Company
15th Aug 20187:00 amRNSYear End Trading Update and Notice of Results
9th Aug 20183:56 pmRNSHolding(s) in Company
30th Jul 20187:00 amRNSDirectorate Changes
11th Jul 201812:07 pmRNSSecond Price Monitoring Extn
11th Jul 201812:02 pmRNSPrice Monitoring Extension
2nd Jul 201811:18 amRNSHolding(s) in Company
29th Jun 201811:50 amRNSHolding(s) in Company
11th Jun 20187:00 amRNSDirectorate Change
8th Jun 20187:00 amRNSBlock listing Interim Review
15th May 20183:58 pmRNSDirector/PDMR Shareholding
8th May 20187:00 amRNSNanoco Announces Major Milestone Payment
2nd May 20187:00 amRNSLaunch of Nanoco 2D Materials Ltd
23rd Apr 20187:00 amRNSExpansion of Material Development Agreement
16th Apr 201811:41 amRNSHolding(s) in Company
10th Apr 20187:00 amRNSHalf-year Results
15th Mar 201810:47 amRNSHolding(s) in Company
15th Mar 20187:00 amRNSNotice of Results
28th Feb 20182:34 pmRNSHolding(s) in Company
9th Feb 201812:59 pmRNSHolding(s) in Company
8th Feb 20187:00 amRNSMaterial Development and Supply Agreement
5th Feb 201812:39 pmRNSHolding(s) in Company
16th Jan 20184:45 pmRNSBLOCKLISTING SIX-MONTHLY RETURN
12th Jan 20182:48 pmRNSResult of AGM
12th Jan 20187:00 amRNSAGM Statement
2nd Jan 201812:07 pmRNSSecond Price Monitoring Extn
2nd Jan 201812:02 pmRNSPrice Monitoring Extension
29th Dec 201712:40 pmRNSSecond Price Monitoring Extn
29th Dec 201712:35 pmRNSPrice Monitoring Extension
19th Dec 20171:11 pmRNSHolding(s) in Company
18th Dec 20171:24 pmRNSHolding(s) in Company
12th Dec 201712:07 pmRNSSecond Price Monitoring Extn
12th Dec 201712:02 pmRNSPrice Monitoring Extension
7th Dec 20177:00 amRNSDirector/PDMR Shareholding
4th Dec 20177:00 amRNSCommercial Supply and License Agreement
30th Nov 20174:43 pmRNSSecond Price Monitoring Extn
30th Nov 20174:35 pmRNSPrice Monitoring Extension
30th Nov 201712:31 pmRNSHolding(s) in Company
30th Nov 20177:00 amRNSAnnual Financial Report
16th Nov 20174:50 pmRNSHolding(s) in Company
16th Nov 20177:00 amRNSPreliminary Results
15th Nov 201710:42 amRNSDirector/PDMR Shareholding
14th Nov 20171:38 pmRNSResult of General Meeting
14th Nov 20177:00 amRNSWebcast of Full Year Results
8th Nov 201712:08 pmRNSHolding(s) in Company
2nd Nov 201710:35 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.